加科思-B(01167.HK)：任命王宜为联席首席执行官
JACOBIOJACOBIO(HK:01167) Ge Long Hui·2025-11-12 22:44

Core Viewpoint - The company is advancing its global strategy by establishing a Co-Chief Executive Officer (Co-CEO) system to enhance cross-regional operational efficiency [1] Group 1 - The board of directors has approved the establishment of the Co-CEO system [1] - Dr. Andrea Wang-Gillam, currently the Chief Medical Officer, will be appointed as Co-CEO effective November 12, 2025 [1]